Although adrenergic b-blocking agents may be used
for the management of hyper-metabolic symptoms, their
use should be limited to a few weeks because of possible
intrauterine growth retardation (21) and, if used in
late pregnancy, they may be associated with transient
neonatal hypoglycemia, apnea, and bradycardia